We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAIA icon
14476
PUT
Gaia
GAIA
$33.3M
-100
Closed -$231
GALT icon
14477
CALL
Galectin Therapeutics
GALT
$356M
-9,700
Closed -$14K
GALT icon
14478
Galectin Therapeutics
GALT
$356M
-428
Closed -$616
GALT icon
14479
PUT
Galectin Therapeutics
GALT
$356M
-2,400
Closed -$3.46K
GAME icon
14480
GameSquare
GAME
$39M
-10,382
Closed -$31.5K
GAME icon
14481
PUT
GameSquare
GAME
$39M
-375
Closed -$1.14K
GAU
14482
PUT
Galiano Gold
GAU
$547M
-1,000
Closed -$590
GBLD
14483
DELISTED
Invesco MSCI Green Building ETF
GBLD
-37,192
Closed -$602K
GCMG icon
14484
PUT
GCM Grosvenor
GCMG
$2.82B
-3,600
Closed -$27.1K
GCMGW
14485
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
-12,502
Closed -$3.66K
GCOW icon
14486
Pacer Global Cash Cows Dividend ETF
GCOW
$3.48B
-247,702
Closed -$8.21M
GENC icon
14487
Gencor Industries
GENC
$265M
-13,276
Closed -$207K
GGLL icon
14488
Direxion Daily GOOGL Bull 2X ETF
GGLL
$958M
-13,913
Closed -$372K
GHTA icon
14489
Goose Hollow Tactical Allocation ETF
GHTA
$41.7M
-20,018
Closed -$515K
GINN icon
14490
Goldman Sachs Innovate Equity ETF
GINN
$215M
-31,590
Closed -$1.55M
GJAN icon
14491
FT Vest US Equity Moderate Buffer ETF January
GJAN
$439M
-11,270
Closed -$367K
GSWO
14492
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.81B
-22,784
Closed -$943K
GLRE icon
14493
CALL
Greenlight Captial
GLRE
$505M
-14,300
Closed -$151K
GLRE icon
14494
Greenlight Captial
GLRE
$505M
-24,190
Closed -$255K
DMRA
14495
CALL
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-440
Closed -$27.7K
DMRA
14496
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-89
Closed -$5.64K
DMRA
14497
PUT
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-112
Closed -$7.06K
GLTR icon
14498
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.67B
-3,296
Closed -$286K
CBIO
14499
CALL
Crescent Biopharma
CBIO
$610M
-160
Closed -$27.8K
CBIO
14500
Crescent Biopharma
CBIO
$610M
-21
Closed -$3.59K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.